The 4,000-year-old drug, most commonly used to treat pain, prevents certain tumours from forming and spreading across the body – findings that are already changing health policies.

New research suggests aspirin may reduce cancer spread in some cases, but experts warn of bleeding risks and urge medical ...

Dr Alfred Jatho, the head of community cancer services at Uganda Cancer Institute in charge of prevention, said the use of ...

A daily regimen of low dose aspirin probably does not significantly reduce the risk of colorectal cancer but may increase the risk of bleeding in the brain area, according to a large-scale analysis of ...

Aspirin reduces the risk of colon cancer recurrence after surgery, but only in patients with a specific genetic marker ...

Aspirin (ASA) likely results in little to no difference in colorectal cancer (CRC) incidence at a follow-up of 5 years to less than 15 years, a review by Chinese investigators reported in The Cochrane ...

One of the world's oldest medicines may have a powerful new purpose. A growing body of clinical evidence suggests that aspirin, the common painkiller with roots stretching back 4,000 years, can ...

“Aspirin is a drug that is readily available globally and extremely inexpensive compared to many modern cancer drugs, which is very positive,” says Anna Martling.

A drug originally derived from willow bark thousands of years ago is sparking a medical revolution. New clinical data and policy shots in 2026 are confirming that aspirin which is the common-over-the ...

New research has found that aspirin use can cut colon cancer cases by half among people with Lynch syndrome, a genetic condition that increases cancer risk. The findings, from long-term trials, have ...